Cloud-Clone
Cloud-Clone Corp. is a Wuhan-headquartered biotech that manufactures and globally distributes proteins, antibodies, ELISA/CLIA/multiplex assay kits, and primary cells to academic researchers and pharmaceutical enterprises, and provides preclinical CRO services for brain disease drug development.
- Company typePrivate
- Founded2009
- HeadquartersKaty, United States
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Cloud-Clone does
Cloud-Clone Corp. (CCC) is a Wuhan, China-headquartered biotech company founded circa 2006–2009 that manufactures and globally distributes research reagents for the life sciences market. Its core product portfolio spans recombinant proteins, polyclonal/monoclonal/recombinant antibodies, ELISA kits (sandwich, competition, high-sensitive, wide-range, instant, mini), chemiluminescent immunoassay (CLIA) kits, multiplex assay kits (FLIA), and more than 560 primary cell types. The company has built two notable proprietary technology assets: a magnetic-bead flow cytometry-based multiplex immunoassay platform backed by over 7,000 in-house validated antibody pairs, and a proprietary antibody library exceeding 27,000 validated targets.
Cloud-Clone operates a dual business model combining high-volume catalog reagent sales with custom development services and a Contract Research Organization (CRO) subsidiary focused on preclinical brain disease research (stroke, Parkinson's disease, traumatic brain injury). It sells directly through its e-commerce website and through a global distributor network spanning the United States, United Kingdom, France, and Japan, with sales offices in Houston, Texas and Wuhan, China. Pricing is not publicly disclosed; customers contact sales for quotes and purchases are transacted on a pay-as-you-go basis for catalog products, with project-based pricing for CRO and custom services.
Cloud-Clone's products are cited in more than 42,000 SCI-indexed publications as of end-2025, including high-impact journals such as Cell, Nature Medicine, and Nature Communications, providing a strong validation and discovery channel for academic and pharmaceutical buyers. The customer base spans academic researchers, medical centers, and pharmaceutical enterprises, with no single anchor customer dominating revenue. The company is privately held with no public funding rounds disclosed and operates with a headcount in the 51–100 range.
Cloud-Clone firmographics
Firmographics- Name
- Cloud-Clone
- Legal name
- CLOUD-CLONE CORP.(CCC)
- Website
- https://cloud-clone.com
- Company type
- Private
- Founded year
- 2009
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cloud-Clone Corp. is a Wuhan-headquartered biotech that manufactures and globally distributes proteins, antibodies, ELISA/CLIA/multiplex assay kits, and primary cells to academic researchers and pharmaceutical enterprises, and provides preclinical CRO services for brain disease drug development.
- Ownership category
- akta.pro rank
Cloud-Clone industry classification
Industry- Product category
- Life Science Research Reagents
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417), In-Vitro Diagnostic Substance Manufacturing (325413)
- SIC
- In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- Preclinical CROs (Discovery/Pharmacology/DMPK) (HLAGAAAB), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL)
Keywords
Where Cloud-Clone is headquartered
LocationHeadquarters
- HQ city
- Katy
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Cloud-Clone business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Technology or R&D, Operations, Supply Chain, Marketing or Sales, Infrastructure
Revenue model
- Research Reagent Products: Sale of proteins, antibodies, ELISA kits, CLIA kits, and multiplex assay kits to research institutions and pharmaceutical companies globally. Products are sold directly through the company's website and through distributor networks.
- Preclinical CRO Services: Contract research organization services for pharmaceutical enterprises and research institutions, providing full-chain preclinical research solutions including project protocol design, animal model construction, multi-index detection, molecular mechanism exploration, and data analysis for brain disease drug development.
- Custom Product Development: Customized service offerings for recombinant proteins, antibodies, ELISA kits, and CLIA kits based on specific customer requirements, as indicated by customization service offers on the website.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Research reagent products including recombinant proteins, antibodies, and assay kits |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels3 records
Cloud-Clone product offering
Product offeringCore offering
Cloud-Clone manufactures and sells life science research reagents including recombinant proteins, antibodies (polyclonal, monoclonal, recombinant), ELISA kits, CLIA kits, multiplex assay kits, and primary cells to research institutions and pharmaceutical companies globally. The company also provides preclinical CRO services specialized in brain disease research (stroke, Parkinson's disease, traumatic brain injury), offering standardized animal models, multi-layer pharmacodynamic evaluation, and full-chain preclinical research solutions.
Product overview
Cloud-Clone Corp. is a biotech company offering a comprehensive portfolio of proteins, antibodies, and assay kits alongside CRO services. The core products include recombinant proteins, antibodies (polyclonal, monoclonal, and recombinant), ELISA kits, CLIA kits, and multiplex assay kits. The company has developed a proprietary antibody library exceeding 27,000 validated targets and offers over 560 types of primary cells. The company operates as both an ODM (Original Design Manufacturer) for assay reagents and analysis equipment, and as a CRO (Contract Research Organization) for animal experiments, particularly specializing in brain disease research including stroke, Parkinson's disease, and traumatic brain injury. Their product portfolio supports research across cytokines, signal transduction, CD & adhesion molecules, enzyme & kinase, apoptosis, tumor immunity, infection immunity, and various disease categories including neuro science, hepatology, and cardiovascular biology.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- Reduces biomarker detection time from 3 days to approximately 2 hours
- +4 more outcomes
Companies that use Cloud-Clone
Customer profileNamed customers4 records
Segments3 records
Ideal customer profiles3 records
Cloud-Clone technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Cloud-Clone partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Global Distributor NetworkcoreCloud-Clone maintains a global distributor network for their research reagents and products, with distribution across multiple countries including the United States, United Kingdom, France, and Japan. Distributors enable the company to reach research institutions and pharmaceutical companies worldwide.
Scale indicators5 records
Recent moves5 records
Expansion highlights5 records
Cloud-Clone competitors and assessment
Company assessmentBroad incumbents
- Thermo Fisher Scientific: Largest life science tools provider with extensive antibody, protein, and assay reagent portfolio plus preclinical CRO services (via PPD acquisition). Comprehensive incumbent competing across all of Cloud-Clone's product and service categories.
- Bio-Rad Laboratories: Major life science tools incumbent operating Bio-Plex multiplex immunoassay platform that competes directly with Cloud-Clone's flow cytometry-based multiplex technology. Broad life science portfolio including clinical diagnostics, providing scale and instrument-anchored distribution advantage.
- Luminex (DiaSorin): Founded the xMAP bead-based multiplex platform that Cloud-Clone's flow cytometry platform explicitly positions against. Now part of DiaSorin, providing established clinical and research presence in multiplexed biomarker detection.
Direct peers
- Sino Biological: China-based biotech offering recombinant proteins, antibodies, ELISA kits, and assay reagents with comparable catalog breadth. Closest direct peer in product portfolio and geographic origin, competing head-to-head on antibodies and recombinant proteins for research use.
- Abcam (Danaher): Major antibody and reagent supplier (now part of Danaher) with extensive catalog comparable to Cloud-Clone's. Direct competitor in primary antibodies and ELISA kits, with overlapping customer base in academic and pharma research.
- GenScript: China-rooted life science tools provider offering recombinant proteins, antibodies, gene synthesis, and preclinical CRO services. Comparable business model combining catalog reagents with custom services, direct competitor particularly in Asia-Pacific markets.
- PeproTech (part of Thermo Fisher): Specializes in recombinant proteins and cytokines for life science research, directly comparable to Cloud-Clone's recombinant protein portfolio. Now part of Thermo Fisher, expanding distribution scale against regional players like Cloud-Clone.
- Wuxi AppTec: China-based CRO offering preclinical research services across multiple therapeutic areas, with significantly larger scale. Comparable brain/CNS preclinical CRO footprint to Cloud-Clone's specialized CRO services; an aspirational scale benchmark.
- Bio-Techne (R&D Systems): Global leader in proteins, antibodies, and ELISA kits through its R&D Systems brand, with a comparable catalog breadth and established multiplex assay platforms (Luminex-based). Direct competitor across nearly all of Cloud-Clone's core reagent categories.
Emerging players
- ABclonal: China-based antibody and reagent provider with rapidly expanding catalog and global distribution. Direct competitor particularly in polyclonal/monoclonal antibodies, representing the rising cohort of Chinese reagent suppliers pressuring Cloud-Clone on price.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Cloud-Clone social profiles
Digital presenceCloud-Clone financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cloud-Clone leadership team
Management profileNumber of profiles
Cloud-Clone funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cloud-Clone M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cloud-Clone
What does Cloud-Clone do?
Cloud-Clone manufactures and sells life science research reagents including recombinant proteins, antibodies (polyclonal, monoclonal, recombinant), ELISA kits, CLIA kits, multiplex assay kits, and primary cells to research institutions and pharmaceutical companies globally. The company also provides preclinical CRO services specialized in brain disease research (stroke, Parkinson's disease, traumatic brain injury), offering standardized animal models, multi-layer pharmacodynamic evaluation, and full-chain preclinical research solutions.
Is Cloud-Clone a public or private company?
Cloud-Clone is a private company. It is classified as unknown and is currently operating.
When was Cloud-Clone founded?
Cloud-Clone was founded in 2009. It employs 11 to 50 people.
Where is Cloud-Clone based?
Cloud-Clone is headquartered in Katy, United States, in the North America region.
How does Cloud-Clone make money?
Three revenue lines are on record. Research Reagent Products are the primary driver. The others are preclinical CRO Services and custom Product Development.
Who are Cloud-Clone's main competitors?
Broad incumbents on record are Thermo Fisher Scientific, Bio-Rad Laboratories and Luminex (DiaSorin). Direct peers are Sino Biological, Abcam (Danaher), GenScript, PeproTech (part of Thermo Fisher), Wuxi AppTec and Bio-Techne (R&D Systems). ABclonal is listed as an emerging player.
Does Cloud-Clone have an API?
No public API is recorded for Cloud-Clone.
What industry is Cloud-Clone in?
Cloud-Clone's product category is Life Science Research Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAGAAAB, Preclinical CROs (Discovery/Pharmacology/DMPK). Its NAICS code is 541714 and its SIC code is 2835.